• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Drug Resist . Thrombosis in Severe Influenza A Pneumonia: Distribution and Risk Factors in Hangzhou, China

tetano

Editor, Senior Moderator
Infect Drug Resist


. 2026 May 13:19:590329.
doi: 10.2147/IDR.S590329. eCollection 2026.
Thrombosis in Severe Influenza A Pneumonia: Distribution and Risk Factors in Hangzhou, China

Nannan Ma[SUP] 1 [/SUP], Qing Pan[SUP] 1 [/SUP], YuanYuan Qi[SUP] 1 [/SUP], FengLin Shao[SUP] 1 [/SUP]


Affiliations
Abstract

Background: Severe viral pneumonia, including that caused by influenza A, can trigger a systemic inflammatory response that can lead to coagulation abnormalities, which substantially increases the risk of life-threatening thrombotic complications.
Objective: This study aimed to examine the distribution of thrombosis and its risk factors among patients with severe influenza A pneumonia to inform early clinical identification and intervention.
Methods: A retrospective analysis was performed on 175 patients with severe influenza A pneumonia who were admitted to the Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine between January 2024 and March 2025. Patients were categorised into a thrombosis group (n = 82) and a control group (n = 93). Clinical data were analysed using univariate and multivariate logistic regression to identify independent risk factors.
Results: The thrombosis group showed significantly higher D-dimer (3.06 [0.95, 12.42] vs 0.90 [0.54, 1.53] μg/mL, p < 0.001) and prolonged prothrombin time (PT) (14.90 [13.56, 18.58] vs 13.70 [13.20, 14.50] s, p < 0.001) than the controls. Multivariate analysis identified elevated D-dimer (odds ratio [OR] = 1.016, p = 0.021) and decreased haemoglobin (OR = 1.026, p = 0.013) as independent risk factors, whereas prolonged PT was independently associated with a lower risk of thrombosis (OR = 0.751, p = 0.010). Venous thrombosis predominated (78.0%), with isolated muscular vein thrombosis (IMVT) being the most common subtype (36.6%).
Conclusion: This study clarified that venous thrombosis, predominantly IMVT and pulmonary embolism, is the primary thrombotic complication in severe influenza A pneumonia. We identified a unique biomarker profile for risk stratification; elevated D-dimer and decreased haemoglobin are independent risk factors, whereas prolonged PT was independently associated with a lower risk of thrombosis. This combination provides a practical tool for early clinical identification of patients at high risk, guiding tailored thromboprophylaxis.

Keywords: D-dimer; influenza A virus; risk factor; severe pneumonia; venous thrombus.

 
Back
Top